Merit Financial Group’s ImmunityBio IBRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$342K	Buy	44,565 +257	+0.6%	+$1.76K	﹤0.01%	1583
2025 Q4	$87.7K	Sell	44,308 -710	-2%	-$1.61K	﹤0.01%	1903
2025 Q3	$111K	Sell	45,018 -4,157	-8%	-$10.7K	﹤0.01%	1730
2025 Q2	$130K	Buy	49,175 +4,931	+11%	+$13.3K	﹤0.01%	1613
2025 Q1	$133K	Buy	44,244 +435	+1%	+$1.32K	﹤0.01%	1341
2024 Q4	$112K	Buy	43,809 +9	+0%	+$37	﹤0.01%	1126
2024 Q3	$163K	Sell	43,800 -19	-0%	-$88	﹤0.01%	799
2024 Q2	$277K	Buy	43,819 +7	+0%	+$46	0.01%	753
2024 Q1	$401K	Buy	43,812 +12	+0%	+$54	0.01%	611
2023 Q4	$220K	Hold	43,800	–	–	0.01%	701
2023 Q3	$74K	Buy	43,800 +20,000	+84%	+$40.2K	﹤0.01%	727
2023 Q2	$66.2K	Hold	23,800	–	–	﹤0.01%	728
2023 Q1	$43.3K	Buy	+23,800	New	+$74K	﹤0.01%	616